The financing includes a EUR 7 million seed investment and more than EUR 3 million in non-dilutive funding currently underway. Other participating investors and one co-founder name were not disclosed in the provided content.
About Cellbricks Therapeutics
A biotech startup developing biofabricated, vascularized living tissue implants for clinical applications, with a long-term goal of producing functional bioprinted human organs.
Berlin, Germany
Read Company ProfileFrequently Asked Questions
What type of funding round did Cellbricks Therapeutics raise?
Cellbricks Therapeutics raised a seed round.
How much did Cellbricks Therapeutics raise in its seed?
Cellbricks Therapeutics raised $10,000,000 EUR in its seed.
When did Cellbricks Therapeutics raise its seed?
Cellbricks Therapeutics raised its seed on 2026-03-25.
Who invested in Cellbricks Therapeutics's seed?
The investors in Cellbricks Therapeutics's seed are: Silicon Roundabout, ACT Venture Partners, SPRIND (Federal Agency for Disruptive Innovation, Germany).
How will Cellbricks Therapeutics use the funds from its seed?
Cellbricks Therapeutics plans to use the funds for: accelerate preclinical validation, launch up to three animal studies, advance the lead adipose tissue implant program, advance biofabricated tissue implants toward clinical use.